|
Title |
Adverse effects of proton pump inhibitors among Indians - A retrospective study
|
|
Authors |
Surabhi Divyangini Ghanashree, Pentapalli
Krishna Kusuma & Venkat Narayana Goutham
|
|
Affiliation |
Department of General Medicine, GITAM Institute of Medical Sciences and Research, GITAM (Deemed to Be University), Visakhapatnam India; *Corresponding author
|
|
|
Surabhi Divyangini Ghanashree - E-mail:
s.divyanginighanashree@gmail.com
|
|
Article Type |
Research Article
|
|
Date |
Received October 1, 2026; Revised October 31, 2026; Accepted October 31, 2026, Published October 31, 2026
|
|
Abstract |
The long-term use of Proton pump inhibitor (PPI) is common. However there is little evidence on its association with haematological and biochemical abnormalities among South Indian people. This retrospective observational study included 100 adults (60 PPI users and 40 matched non-users). We evaluated thrombocytopenia, anaemia, serum iron and ferritin and magnesium levels. Thrombocytopenia was significantly more prevalent among PPI users than non-users (53.3% vs. serum ferritin was significantly lower (41.75 vs. 144.25 ng/mL, p=0.001), while serum iron was higher (72.30 vs. 53.78 mcg/dL, p=0.005) in PPI users. PPI duration was negatively correlated with Haemoglobin (r=−0.49), serum iron (r=−0.27) and ferritin (r=−0.41) and no associations were found between anaemia and hypomagnesaemia. Thus, chronic use of a PPI is associated with thrombocytopenia and low iron stores, so it should be monitored regularly while taking this medication for a long period. |
|
Keywords |
Proton pump inhibitors (PPIs), thrombocytopenia, iron deficiency, hypomagnesaemia, adverse effects, long-term therapy
|
|
Citation |
Ghanashree et al. Bioinformation 22(10): 6924 -6930 (2026)
|
|
Edited by |
P Kangueane
|
|
ISSN |
0973-2063
|
|
Publisher |
|
|
License |
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
|
|
|
|